POMALIDOMIDA GRINDEKS 4mg capsules medication leaflet

L04AX06 pomalidomide • Antineoplastic and immunomodulating agents | Immunosuppressants | Other immunosuppressants

Pomalidomide is an immunomodulatory agent used in the treatment of relapsed or refractory multiple myeloma. It works by stimulating the immune system and inhibiting tumor cell growth.

The medication is taken orally, as directed by a doctor, usually once daily in treatment cycles. It is important for patients to follow the treatment regimen and undergo regular tests to monitor the therapy's effects.

Patients should be aware of potential side effects, such as anemia, fatigue, or infections. It is important to inform the doctor of any unusual symptoms.

Common side effects include anemia, fatigue, and neutropenia. In rare cases, severe reactions such as deep vein thrombosis or allergic reactions may occur. Patients should be informed of these risks before use.

General data about POMALIDOMIDA GRINDEKS 4mg

Substance: pomalidomide

Date of last drug list: 10-04-2026

Commercial code: W70887001

Concentration: 4mg

Pharmaceutical form: capsules

Quantity: 21

Product type: generic

Price: 19789.24 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: AS GRINDEKS - LETONIA

Holder: AS GRINDEKS - LETONIA

Number: 15803/2025/01

Shelf life: 4 years

Concentrations available for pomalidomide

1mg, 2mg, 3mg, 4mg

Compensation lists for POMALIDOMIDA GRINDEKS 4mg AS GRINDEKS

NHP 3 (C2) - NHP oncology

Price

Copayment

Patient

19789.24 RON

3304.08 RON

16485.16 RON